KNG1, kininogen 1, 3827

N. diseases: 279; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Sex differences in behavior and expression of CGRP-related genes in a rodent model of chronic migraine. 21521205 2011
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Evidence of TRPV1 receptor and PKC signaling pathway in the antinociceptive effect of amyrin octanoate. 19646975 2009
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. 18234883 2008
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Impaired nociception and inflammatory pain sensation in mice lacking the prokineticin receptor PKR1: focus on interaction between PKR1 and the capsaicin receptor TRPV1 in pain behavior. 16793879 2006
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Antinociceptive properties of mixture of alpha-amyrin and beta-amyrin triterpenes: evidence for participation of protein kinase C and protein kinase A pathways. 15626726 2005
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Antinociceptive action of the extract and the flavonoid quercitrin isolated from Bauhinia microstachya leaves. 16259764 2005
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human The involvement of K+ channels and Gi/o protein in the antinociceptive action of the gallic acid ethyl ester. 10499367 1999
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Oral antinociception and oedema inhibition produced by NPC 18884, a non-peptidic bradykinin B2 receptor antagonist. 10543429 1999
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Pharmacological modulation of secondary mediator systems--cyclic AMP and cyclic GMP--on inflammatory hyperalgesia. 10401557 1999
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Anti-hyperalgesic properties of the extract and of the main sesquiterpene polygodial isolated from the barks of Drymis winteri (Winteraceae). 9714424 1998
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human The nonpeptide B2 receptor antagonist FR173657: inhibition of effects of bradykinin related to its role in nociception. 9720808 1998
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human S14080, a peripheral analgesic acting by release of an endogenous circulating opioid-like substance. 7881729 1995
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. 7582491 1995
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human BW373U86, a delta-opioid receptor agonist, reverses bradykinin-induced thermal allodynia in rhesus monkeys. 7493622 1995
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Kappa- and delta-opioids block sympathetically dependent hyperalgesia. 2010815 1991
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia. 2128375 1990
CUI: C0751212
Disease: Hyperalgesia, Secondary
Hyperalgesia, Secondary
0.300 Biomarker phenotype CTD_human Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. 3061568 1988